Amplification of a gene encoding a p53-associated protein in human sarcomas

Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., Vogelstein, B.·1992·Nature
DOI 10.1038/358080a0

Cited by (1,001)

Items 301–400 of 1,001

  1. The Role of p53 in Cell Cycle Regulation
    Phillip H. Shaw · 1996 · Pathology - Research and Practice
  2. The loss of mdm2 induces p53 mediated apoptosis
    Sohela de Rozìeres, Ruth Ben-Yakar Maya, Moshe Oren, Guillermina Lozano · 2000 · Oncogene
  3. Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas
    Anne Forus, Daniël Olde Weghuis, Dominique Smeets, Øystein Fodstad, Ola Myklebost, Ad Geurts van Kessel · 1995 · Genes Chromosomes and Cancer
  4. The Emerging p53 Gene Family
    William G. Kaelin · 1999 · JNCI Journal of the National Cancer Institute
  5. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression
    Jeffrey G. Mussman, Henning F. Horn, Patrick E Carroll, Masaru Okuda, Pheruza Tarapore, Lawrence A. Donehower, Kenji Fukasawa · 2000 · Oncogene
  6. Gains of 12q13-14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery
    Beata Bode‐Lesniewska, Jianming Zhao, Ernst‐Jan M. Speel, A. Biraima, Marko Ivan Turina, Paul Komminoth, Philipp U. Heitz · 2001 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  7. TP53 Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter Study
    Jay Steven Wunder, Nalan Gökgöz, Robert K. Parkes, Shelley B. Bull, Sasha Eskandarian, Aileen M. Davis, Christopher P. Beauchamp, Ernest U. Conrad, Robert John Grimer, John H. Healey et al. · 2005 · Journal of Clinical Oncology
  8. The Mdm2 Oncoprotein Interacts with the Cell Fate Regulator Numb
    Tamar Juven‐Gershon, Ohad Shifman, Tamar Unger, Adi Elkeles, Ygal Haupt, Moshe Oren · 1998 · Molecular and Cellular Biology
  9. Cell Surface Expression of Epidermal Growth Factor Receptor and Her-2 with Nuclear Expression of Her-4 in Primary Osteosarcoma
    Dennis P.M. Hughes, Dafydd G. Thomas, Thomas J. Giordano, Laurence H. Baker, Kevin T. McDonagh · 2004 · Cancer Research
  10. An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2
    Susan C. Evans, Meena Viswanathan, Jason D. Grier, Meera Narayana, Adel K. El‐Naggar, Guillermina Lozano · 2001 · Oncogene
  11. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas
    B Wadayama, Junya Toguchida, Toshikazu Yamaguchi, MS Sasaki, T. Yamamuro · 1993 · British Journal of Cancer
  12. Translational regulation of human p53 gene expression.
    Loning Fu, Mark David Minden, Samuel Benchimol · 1996 · The EMBO Journal
  13. p53 abnormalities in different subtypes of human sarcomas.
    Åshild Kristin Andreassen, Tove Øyjord, Eivind J. Hovig, R Holm, Viví Ann Flørenes, J. M. Nesland, Ola Myklebost, Johan Høie, Øyvind Sverre Bruland, Anne‐Lise Børresen‐Dale · 1993 · PubMed
  14. E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis
    Ju Liu, Congcong Zhang, X L Wang, Peter Ly, В. А. Белый, Zijun Yidan Xu-Monette, Ken H. Young, Wenwei Hu, Zhaohui Feng · 2014 · Cell Death and Differentiation
  15. An Inhibitor of Nuclear Export Activates the p53 Response and Induces the Localization of HDM2 and p53 to U1A-Positive Nuclear Bodies Associated with the PODs
    Sonia Laı́n, Carol Midgley, Alison Sparks, Ellen Birgitte Lane, David Philip Lane · 1999 · Experimental Cell Research
  16. Physical and Functional Interaction between Wild-Type p53 and mdm2 Proteins
    Dale S. Haines, John E. Landers, Linda J. Engle, Donna L. George · 1994 · Molecular and Cellular Biology
  17. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21–q22 in soft tissue sarcomas
    Anne Forus, Daniël Olde Weghuis, Dominique Smeets, Øystein Fodstad, Ola Myklebost, Ad Geurts van Kessel · 1995 · Genes Chromosomes and Cancer
  18. PLAG1 Alterations in Lipoblastoma
    David Gisselsson, Michele K. Hibbard, Paola Dal Cin, Raf Sciot, Bae‐Li Hsi, Harry P. Kozakewich, Jonathan A. Fletcher · 2001 · American Journal Of Pathology
  19. Strategies for therapeutic targeting of the p53 pathway in cancer
    Klas G. Wiman · 2006 · Cell Death and Differentiation
  20. The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy
    Yao Liu, Xiaohui Wang, Guan Wang, Yu‐Shang Yang, Yong Yuan, Liang Ouyang · 2019 · European Journal of Medicinal Chemistry
  21. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53
    Felix Hoppe‐Seyler, Karin Butz · 1993 · Journal of Virology
  22. Prognostic implications of chromosome 17p deletions in human medulloblastomas
    Surinder K. Batra, Roger E. McLendon, Ja Seok Koo, Shobha Castelino‐Prabhu, Herbert E. Fuchs, Jeffrey P. Krischer, Henry S. Friedman, Darell D. Bigner, Sandra H. Bigner · 1995 · Journal of Neuro-Oncology
  23. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.
    Corey Raffel, Lori A. Frederick, Judith Rich O'Fallon, Pamela Atherton-Skaff, Arie Perry, Robert Brian Jenkins, Charles David James · 1999 · PubMed
  24. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours
    Lars Gunnar Kindblom, M. Ahld�n, Jeanne M. Meis‐Kindblom, Göran Stenman · 1995 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  25. MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation
    Masahiko Higashiyama, Osamu Doi, Ken Kodama, Hiroshi Yokouchi, Tsutomu Kasugai, S Ishiguro, K Takami, T Nakayama, Isamu Nishisho · 1997 · British Journal of Cancer
  26. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Jiří Lukáš, D Q Gao, Mariana Keshmeshian, Wenhsiang Wen, Denice D Tsao-Wei, Steven A. Rosenberg, M F Press · 2001 · PubMed
  27. MDM2-dependent ubiquitination of nuclear and cytoplasmic P53
    Zhong Kang Yu, Rory K. Geyer, Carl G. Maki · 2000 · Oncogene
  28. Interaction of adenoviral proteins with pRB and p53
    Elizabeth Morán · 1993 · The FASEB Journal
  29. Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53–MDM2 Protein–Protein Interaction
    Zhuang, Chunlin, Miao, Zhenyuan, Zhu, Lingjian, Dong, Guoqiang, Guo, Zizhao, Wang, Shengzheng, Zhang, Yongqiang, Wu, Yuelin, Yao, Jianzhong, Sheng, Chunquan et al. · 2012 · Journal of Medicinal Chemistry
  30. Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
    Victor W. van Beusechem, Petra B. van den Doel, Jacques Grill, Herbert M. Pinedo, Winald R. Gerritsen · 2002 · PubMed
  31. Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors
    Jianming Zhao, Jürgen Roth, Beata Bode‐Lesniewska, Madeleine Pfaltz, Philipp U. Heitz, Paul Komminoth · 2002 · Genes Chromosomes and Cancer
  32. Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End
    Amanda R. Wasylishen, Guillermina Lozano · 2016 · Cold Spring Harbor Perspectives in Medicine
  33. Degradation of MDM2 by the Interaction between Berberine and DAXX Leads to Potent Apoptosis in MDM2-Overexpressing Cancer Cells
    Xiaoling Zhang, Lubing Gu, Jiansha Li, Noopur Shah, Jing He, Lin Yang, Qun Hu, Muxiang Zhou · 2010 · Cancer Research
  34. The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans
    Pant, Vinod, Quintás-Cardama, Alfonso, Lozano, Guillermina · 2012 · Blood
  35. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice
    Domenico Migliorini, Sven Bogaerts, Dieter Defever, Rajesh Vyas, Geertrui Denecker, Enrico Radaelli, Aleksandra Zwolińska, Vanessa Depaepe, Tino Hochepied, William C. Skarnes et al. · 2011 · Journal of Clinical Investigation
  36. MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension
    Hui Shen, Jiao Zhang, Chen Wang, Pritesh Jain, Mingmei Xiong, Xinxing Shi, Yuyang Lei, Shanshan Chen, Qian Yin, Patricia A. Thistlethwaite et al. · 2020 · Circulation
  37. Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene
    Maohua Zhou, AM Yeager, Stephen D. Smith, Harry W. Findley · 1995 · Blood
  38. Characterization of human Gadd45, a p53-regulated protein.
    France Carrier, Melvyn Lionel Smith, I Bae, Katherine E. Kilpatrick, Timothy J. Lansing, Cheau Yun Chen, Marcy Engelstein, Stephen Henry Friend, William David Henner, T M Gilmer · 1994 · Journal of Biological Chemistry
  39. Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis, carcinomas and liver metastases
    Margret Dueck, S Riedl, Ulf Hinz, Andrea A. Tandara, Peter M�ller, Christian H. Herfarth, Andréas Faissner · 1999 · International Journal of Cancer
  40. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines
    Julie E. Burns, MC Baird, LJ Clark, P A Burns, Kirsten G. Edington, C Chapman, Rod Thomas Mitchell, Gerry Robertson, David S. Soutar, Eric Kenneth Parkinson · 1993 · British Journal of Cancer
  41. A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development
    Post, Sean M., Quintás-Cardama, Alfonso, Pant, Vinod, Iwakuma, Tomoo, Hamir, Amir, Jackson, James G., Maccio, Daniela R., Bond, Gareth L., Johnson, David G., Levine, Arnold J. et al. · 2010 · Cancer Cell
  42. P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
    Kathleen M. Farmer, Gaurav Ghag, Nicha Puangmalai, Mauro Montalbano, Nemil N. Bhatt, Rakez Kayed · 2020 · Acta Neuropathologica Communications
  43. Biology of Osteogenic Sarcoma
    Lisa L. Wang · 2005 · The Cancer Journal
  44. The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma.
    M. Saeed Sheikh, Zhi Ming Shao, Arif Hussain, Joseph A. Fontana · 1993 · PubMed
  45. Discovery of a Small Molecule MDM2 Inhibitor (AMG 232) for Treating Cancer
    Rew, Yosup, Sun, Daqing · 2014 · Journal of Medicinal Chemistry
  46. MDM2 and MDMX: Alone and together in regulation of p53.
    Miriam Shadfan, Vanessa Lopez-Pajares, Zhi-Min Yuan · 2012 · PubMed
  47. USP7: Novel Drug Target in Cancer Therapy
    Zhiru Wang, Wen-Ting Kang, Yinghua You, Jing‐Ru Pang, Hongmei Ren, Zhenhe Suo, Hong‐Min Liu, Yi‐Chao Zheng · 2019 · Frontiers in Pharmacology
  48. Oligomerization Is Required for p53 to be Efficiently Ubiquitinated by MDM2
    Carl G. Maki · 1999 · Journal of Biological Chemistry
  49. p53 induces the expression of its antagonist p73ΔN, establishing an autoregulatory feedback loop
    Natalia N Kartasheva, Ana Contente, Claudia Lenz-Stöppler, Judith C. Roth, Matthias Dobbelstein · 2002 · Oncogene
  50. Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
    LeBron, Cynthia, Chen, Lihong, Gilkes, Daniele M, Chen, Jiandong · 2006 · The EMBO Journal
  51. Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations
    Alyson W. MacInnes, Adam Amsterdam, Charles A. Whittaker, Nancy H. Hopkins, Jacqueline A. Lees · 2008 · Proceedings of the National Academy of Sciences
  52. MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas
    Vladimír Balik, Josef Srovnal, Igor J. Sulla, Ondřej Kalita, Tatiana Foltánová, Miroslav Vaverka, Lumír Hrabálek, Marián Hajdúch · 2013 · Journal of Neuro-Oncology
  53. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status
    Amanda H McCann, A Kirley, D. N. Carney, Niamh Corbally, Hilary M. Magee, George Keating, Peter A. Dervan · 1995 · British Journal of Cancer
  54. Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide
    Anne G. Ostermeyer, Erik Runko, Blonka Winkfield, Brand Ahn, Ute Martha Moll · 1996 · Proceedings of the National Academy of Sciences
  55. Accumulation of wild type p53 protein in human astrocytomas.
    Mari‐Paz Rubio, Andreas von Deimling, David W. Yandell, Otmar Dieter Wiestler, James F. Gusella, David N. Louis · 1993 · PubMed
  56. p53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines
    Alan C. Taylor, Lili Shu, Mary K. Danks, Catherine A. Poquette, Sheetal Shetty, Mathew J. Thayer, Peter J. Houghton, Linda C. Harris · 2000 · Medical and Pediatric Oncology
  57. Immunohistochemical detection of P53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs
    Jens Peter Teifke, Christiane V. Löhr · 1996 · Journal of Comparative Pathology
  58. Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5
    Jose G. Teodoro, P E Branton · 1997 · Journal of Virology
  59. Functional Domains of Wild-Type and Mutant p53 Proteins Involved in Transcriptional Regulation, Transdominant Inhibition, and Transformation Suppression
    Tamar Unger, Judy A. Mietz, Martin Scheffner, Carole Yee, Peter M. Howley · 1993 · Molecular and Cellular Biology
  60. Keeping an old friend under control: regulation of p53 stability
    Michael H.G. Kubbutat, Karen H. Vousden · 1998 · Molecular Medicine Today
  61. Characterization of the 12q13-15 amplicon in soft tissue tumors
    Mef Christina Nilbert, Anders Rydholm, Felix Mitelman, Paul S. Meltzer, Nils Mandahl · 1995 · Cancer Genetics and Cytogenetics
  62. Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia
    Mitchell B. Diccianni, Alice Lin-Tsing Yu, Michael Hsiao, Sujoy Mukherjee, L-E Shao, Alice Lin-Tsing Yu · 1994 · Blood
  63. Characterization of the 12q15 <i>MDM2</i> and 12q13‐14 <i>CDK4</i> amplicons and clinical correlations in osteosarcoma
    Mejia‐Guerrero, Salvador, Quejada, Michael, Gokgoz, Nalan, Gill, Mona, Parkes, Robert K., Wunder, Jay S., Andrulis, Irene L. · 2010 · Genes, Chromosomes and Cancer
  64. Ubiquitin‐mediated control of oncogene and tumor suppressor gene products
    Kyoko Kitagawa, Yojiro Kotake, Masatoshi Kitagawa · 2009 · Cancer Science
  65. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells
    Samisubbu R. Naidu, Ian M. Love, Anthony N. Imbalzano, Steven R. Grossman, Elliot J. Androphy · 2009 · Oncogene
  66. PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment.
    Jing Dong Su, Lindsey D. Mayo, David B. Donner, Donald L. Durden · 2003 · PubMed
  67. MDM2 gene amplification in bone and soft‐tissue tumors: Association with tumor progression in differentiated adipose‐tissue tumors
    Tomitaka Nakayama, Junya Toguchida, B Wadayama, Hiroshi Kanoe, Yoshihiko Kotoura, Masao S. Sasaki · 1995 · International Journal of Cancer
  68. Polymorphism in the tumor necrosis factor-? promotor region and in the heat shock protein 70 genes associated with malignant tumors
    Lotfi Chouchane, Slim Ben Ahmed, Sami Baccouche, Sami Remadi · 1997 · Cancer
  69. Proteolytic Cleavage of the mdm2 Oncoprotein during Apoptosis
    Chen, Lihong, Marechal, Vincent, Moreau, Jacques, Levine, Arnold J., Chen, Jiandong · 1997 · Journal of Biological Chemistry
  70. Aberrant Expression of the Cell Cycle Associated Proteins TP53, MDM2, p21, p27, cdk4, Cyclin D1, RB, and EGFR in Cervical Carcinomas
    Hanne Skomedal, Gunnar Balle Kristensen, Agnes Kathrine Lie, Ruth Holm · 1999 · Gynecologic Oncology
  71. Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter
    Shivakumar, Chittari V., Brown, Doris R., Deb, Sumitra, Deb, Swati Palit · 1995 · Molecular and Cellular Biology
  72. Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A
    Müller, Christoph R., Paulsen, Erik B., Noordhuis, Paul, Pedeutour, Florence, Sæter, Gunnar, Ola Myklebost · 2007 · International Journal of Cancer
  73. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Muxiang Zhou, Lubing Gu, Harry W. Findley, Rong Jiang, William G. Woods · 2003 · PubMed
  74. HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma.
    David Polsky, Boris C. Bastian, C Hazan, K Melzer, J Pack, A Houghton, Klaus Johannes BUSAM, Carlos Cordon‐Cardo, Iman Osman · 2001 · PubMed
  75. The gadd and MyD Genes Define a Novel Set of Mammalian Genes Encoding Acidic Proteins That Synergistically Suppress Cell Growth
    Qimin Zhan, Kenneth A. Lord, Isaac Alamo, Mary Christine Hollander, France Carrier, David Ron, Kurt W. Kohn, Barbara Hoffman‐Liebermann, Dan A. Liebermann, Albert J. Fornace · 1994 · Molecular and Cellular Biology
  76. Ionizing Radiation-Induced Responses in Human Cells with Differing TP53 Status
    Razmik Mirzayans, Bonnie Andrais, April Scott, Ying Wang, David L. Murray · 2013 · International Journal of Molecular Sciences
  77. In vivocloning of PCR products inE.coli
    Jonathan D. Oliner, Kenneth W. Kinzler, Bert Vogelstein · 1993 · Nucleic Acids Research
  78. Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBP beta (NF-IL6) activity by p53 species
    Lola Margulies, Pravin B. Sehgal · 1993 · Journal of Biological Chemistry
  79. A Correlative Study of p53 Protein Alteration and p53 Gene Mutation in Glioblastoma Multiforme
    Elizabeth W. Newcomb, William J. Madonia, Sobha Pisharody, Frederick F. Lang, Maxim Koslow, Douglas Craig Miller · 1993 · Brain Pathology
  80. p53: A Cell Cycle Regulator Activated by DNA Damage
    Galina Selivanova, Klas G. Wiman · 1995 · Advances in cancer research
  81. Preclinical Efficacy of the MDM2 Inhibitor RG7112 in <i>MDM2</i> -Amplified and <i>TP53</i> Wild-type Glioblastomas
    Verreault, Maite, Schmitt, Charlotte, Goldwirt, Lauriane, Pelton, Kristine, Haidar, Samer, Levasseur, Camille, Guehennec, Jeremy, Knoff, David, Labussière, Marianne, Marie, Yannick et al. · 2016 · Clinical Cancer Research
  82. Tumor-suppressor p53 and the cell cycle
    Mary Ellen Perry, Arnold J. Levine · 1993 · Current Opinion in Genetics & Development
  83. The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians
    Stian Knappskog, Merete Bjørnslett, Line Merethe Myklebust, Petra E.A. Huijts, Maaike P.G. Vreeswijk, Hege Edvardsen, Yongli Guo, Xuemei Zhang, Ming Yang, Sanna K. Ylisaukko‐oja et al. · 2011 · Cancer Cell
  84. Activation of p53 by roscovitine-mediated suppression of MDM2 expression
    Wenge Lu, Lihong Chen, Yanhua Peng, Jiandong Chen · 2001 · Oncogene
  85. Tumourigenesis associated with the p53 tumour suppressor gene
    Fuju Chang, Stina Syrjänen, Arja I. Tervahauta, Kari Juhani Syrjänen · 1993 · British Journal of Cancer
  86. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis
    Soon‐Myoung Kang, Kiyoshi Maeda, Naoyoshi Onoda, Yong‐Suk Chung, Bunzo Nakata, Yukio Nishiguchi, Michio Sowa · 1997 · International Journal of Cancer
  87. Binding Induced Folding in p53−MDM2 Complex
    Haifeng Chen, Ray Luo · 2007 · Journal of the American Chemical Society
  88. The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells
    David Gisselsson, Mattias Höglund, Fredrik Mertens, Bertil Johansson, Paola Dal Cin, Herman VAN DEN BERGHE, William C. Earnshaw, Felix Mitelman, Nils Mandahl · 1999 · Human Genetics
  89. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes
    Jun Yokota, Takashi Sügimura · 1993 · The FASEB Journal
  90. The Role of the p53 Tumor Suppressor Gene in Squamous Cell Carcinoma of the Head and Neck
    John K. Field, Zlatko P. Pavelić, Demetrios A. Spandidos, Peter J. Stambrook, Ashley Jones, Jack L. Gluckman · 1993 · Archives of Otolaryngology - Head and Neck Surgery
  91. Regulation of p53 Nuclear Export through Sequential Changes in Conformation and Ubiquitination
    Linghu Nie, Mark M. Sasaki, Carl G. Maki · 2007 · Journal of Biological Chemistry
  92. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus
    Keith D. Robertson, Peter A. Jones · 1999 · Oncogene
  93. The MDM2 promoter polymorphism SNP309T→G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck
    Pia Alhopuro, Sanna K. Ylisaukko‐oja, Walter J. Koskinen, P Bono, J Arola, Heikki J. Järvinen, Jukka‐Pekka Mecklin, Timo S. Atula, R Kontio, A A Mäkitie et al. · 2005 · Journal of Medical Genetics
  94. p53, p63 and p73 – solos, alliances and feuds among family members
    Ute Martha Moll, Susan H. Erster, Alex Zaika · 2001 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  95. Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award Lecture.
    Deborah A. Freedman, Arnold J. Levine · 1999 · PubMed
  96. p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk, Roberto Salvi, Manuela Argentini, Christine Dureuil, Isabelle Delumeau, Joseph Abecassis, Laurent Debüssche, Bohdan Wasylyk · 1999 · Oncogene
  97. The Tumor Suppressor p53 Regulates Its Own Transcription
    Abdul M. Deffie, Hongyun Wu, V Reinke, Guillermina Lozano · 1993 · Molecular and Cellular Biology
  98. p53 and the Li-Fraumeni syndrome
    David M. Malkin · 1994 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  99. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.
    Paul Scott Thorner, Jeremy Andrew Squire, Susan Chilton‐MacNeill, Paula M. Marrano, Jane Bayani, David M. Malkin, Mark Greenberg, Adonis Lorenzana, Maria Zieleńska · 1996 · Europe PMC (PubMed Central)
  100. Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification
    Jongho Park, Seung Wook Yang, Jung Mi Park, Seung Hyeun Ka, Ji-Hoon Kim, Young‐Yun Kong, Young Joo Jeon, Jae Hong Seol, Chin Ha Chung · 2016 · Nature Communications